Med anledning av pressmeddelanden och nyheter, bjuder Hamlet BioPharma in till en livesänd digital pressträff torsdag 28 augusti, 2025, klockan 12.00....
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces the completion of the succ...
Lund, 11 augusti 2025, Hamlet BioPharma, ett innovativt läkemedelsbolag som utvecklar nya terapier mot cancer och infektioner, meddelar idag att extra...
Med anledning av pressmeddelanden och nyheter, bjuder Hamlet BioPharma in till en livesänd digital pressträff fredagen den 25 juli, 2025, klockan 11.3...
Aktieägarna i Hamlet BioPharma AB (publ) (”Hamlet BioPharma” eller ”Bolaget”), org.nr 556568-8958, kallas härmed till extra bolagsstämma 11 augusti 20...
Lund, 18 July 2025, Hamlet BioPharma, an innovative pharmaceutical company that develops new therapies against cancer and infections, announces today ...
Lund, 18 juli 2025, Hamlet BioPharma, ett innovativt läkemedelsbolag som utvecklar nya terapier mot cancer och infektioner, meddelar idag att bolaget ...
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, today announces the successful first...
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, today announces progress in Tubercul...
As previously announced Hamlet BioPharma invites you to our monthly investors’ meeting to be held on the 18th of June 2025, at 12:00.
Please click on ...
